BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23363813)

  • 21. Prognostic significance of peripheral CD8+CD28+ and CD8+CD28- T cells in advanced non-small cell lung cancer patients treated with chemo(radio)therapy.
    Liu C; Jing W; An N; Li A; Yan W; Zhu H; Yu J
    J Transl Med; 2019 Oct; 17(1):344. PubMed ID: 31623615
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCR7 expression and memory T cell diversity in humans.
    Campbell JJ; Murphy KE; Kunkel EJ; Brightling CE; Soler D; Shen Z; Boisvert J; Greenberg HB; Vierra MA; Goodman SB; Genovese MC; Wardlaw AJ; Butcher EC; Wu L
    J Immunol; 2001 Jan; 166(2):877-84. PubMed ID: 11145663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotype and molecular signature of CD8+ T cell subsets in T cell- mediated rejections after kidney transplantation.
    Ko EJ; Seo JW; Kim KW; Kim BM; Cho JH; Kim CD; Seok J; Yang CW; Lee SH; Chung BH
    PLoS One; 2020; 15(6):e0234323. PubMed ID: 32530943
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD45RA
    Kunert A; Basak EA; Hurkmans DP; Balcioglu HE; Klaver Y; van Brakel M; Oostvogels AAM; Lamers CHJ; Bins S; Koolen SLW; van der Veldt AAM; Sleijfer S; Mathijssen RHJ; Aerts JGJV; Debets R
    J Immunother Cancer; 2019 Jun; 7(1):149. PubMed ID: 31176366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of circulating tumor cell subpopulations in patients with head and neck squamous cell carcinoma (HNSCC).
    Weller P; Nel I; Hassenkamp P; Gauler T; Schlueter A; Lang S; Dountsop P; Hoffmann AC; Lehnerdt G
    PLoS One; 2014; 9(12):e113706. PubMed ID: 25479539
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The frequency and suppressor function of CD4+CD25highFoxp3+ T cells in the circulation of patients with squamous cell carcinoma of the head and neck.
    Strauss L; Bergmann C; Gooding W; Johnson JT; Whiteside TL
    Clin Cancer Res; 2007 Nov; 13(21):6301-11. PubMed ID: 17975141
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High numbers of differentiated CD28null CD8+ T cells are associated with a lowered risk for late rejection and graft loss after kidney transplantation.
    Betjes MGH; Litjens NHR
    PLoS One; 2020; 15(2):e0228096. PubMed ID: 32023273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dynamic changes in immune cell profile in head and neck squamous cell carcinoma: Immunomodulatory effects of chemotherapy.
    Takahashi H; Sakakura K; Mito I; Ida S; Chikamatsu K
    Cancer Sci; 2016 Aug; 107(8):1065-71. PubMed ID: 27228557
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cartography of gene expression in CD8 single cells: novel CCR7- subsets suggest differentiation independent of CD45RA expression.
    Monteiro M; Evaristo C; Legrand A; Nicoletti A; Rocha B
    Blood; 2007 Apr; 109(7):2863-70. PubMed ID: 17148588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tadalafil reduces myeloid-derived suppressor cells and regulatory T cells and promotes tumor immunity in patients with head and neck squamous cell carcinoma.
    Weed DT; Vella JL; Reis IM; De la Fuente AC; Gomez C; Sargi Z; Nazarian R; Califano J; Borrello I; Serafini P
    Clin Cancer Res; 2015 Jan; 21(1):39-48. PubMed ID: 25320361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive T-cell immunophenotyping and next-generation sequencing of human papillomavirus (HPV)-positive and HPV-negative head and neck squamous cell carcinomas.
    Poropatich K; Fontanarosa J; Swaminathan S; Dittmann D; Chen S; Samant S; Zhang B
    J Pathol; 2017 Nov; 243(3):354-365. PubMed ID: 28771750
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perforin, CD28 and CD95 expression in circulating CD4 and CD8 cells as predictors of head and neck (H&N) cancer patient survival.
    Laytragoon-Lewin N; Jönson F; Lundgren J; Rutqvist LE; Wikby A; Löfgren S; Lewin F
    Med Oncol; 2014 Dec; 31(12):290. PubMed ID: 25344268
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Systemic inflammatory markers as independent prognosticators of head and neck squamous cell carcinoma.
    Rassouli A; Saliba J; Castano R; Hier M; Zeitouni AG
    Head Neck; 2015 Jan; 37(1):103-10. PubMed ID: 24339165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differentiation of human CD8(+) T cells from a memory to memory/effector phenotype.
    Tomiyama H; Matsuda T; Takiguchi M
    J Immunol; 2002 Jun; 168(11):5538-50. PubMed ID: 12023349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-CD3/anti-CD28 monoclonal antibody-coated suture enhances the immune response of patients with head and neck squamous cell carcinoma.
    Shibuya TY; Wei WZ; Zormeier M; Ensley J; Sakr W; Mathog RH; Meleca RJ; Yoo G; June CH; Levine B; Lum LG
    Arch Otolaryngol Head Neck Surg; 1999 Nov; 125(11):1229-34. PubMed ID: 10555694
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of circulating tumor cells for prediction of recurrence after adjuvant chemoradiation in locally advanced squamous cell carcinoma of the head and neck.
    Tinhofer I; Konschak R; Stromberger C; Raguse JD; Dreyer JH; Jöhrens K; Keilholz U; Budach V
    Ann Oncol; 2014 Oct; 25(10):2042-2047. PubMed ID: 25057171
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Neutrophil to lymphocyte ratio in peripheral blood: a novel independent prognostic factor in patients with head and neck squamous cell carcinoma].
    Wu F; Wu LL; Zhu LX
    Zhonghua Zhong Liu Za Zhi; 2017 Jan; 39(1):29-32. PubMed ID: 28104030
    [No Abstract]   [Full Text] [Related]  

  • 38. Effector memory T-cell frequencies in relation to tumour stage, location and HPV status in HNSCC patients.
    Turksma AW; Bontkes HJ; van den Heuvel H; de Gruijl TD; von Blomberg BM; Braakhuis BJ; Leemans CR; Bloemena E; Meijer CJ; Hooijberg E
    Oral Dis; 2013 Sep; 19(6):577-84. PubMed ID: 23176702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered proportions of naïve, central memory and terminally differentiated central memory subsets among CD4+ and CD8 + T cells expressing CD26 in patients with type 1 diabetes.
    Matteucci E; Ghimenti M; Di Beo S; Giampietro O
    J Clin Immunol; 2011 Dec; 31(6):977-84. PubMed ID: 21887518
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
    Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
    APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.